Quantification of CMV DNA during NIPS is accurate and sensitive for CMV viral load; stratifies risk for primary maternal infection, cCMV.
The hemophagocytic lymphohistiocytosis market is expected to increase due to the launch of emerging therapies, such as plonmarlimab (TJ Biopharma), ELA026 (Electra Therapeutics), MAS825 (Novartis) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback